»Profit Hunter by Equitymaster

On This Day - 7 FEBRUARY 2020
CoronaVirus' Impact on Indian Markets - And One Stock With the Potential to Make Crores...

Richa Agarwal, Research analyst

My friend recently called me to lament about her cancelled trip to Hong Kong.

With Coronavirus fever taking over, I'm glad she did.

She also told me about this conspiracy theory making the rounds...

That the virus and its transmission to humans has nothing to do with unhygienic wildlife trade or China's dietary preferences.

It is in fact a much bigger blunder...

...a leak from a bio warfare laboratory in China.

This sounded sinister enough to give me goosebumps.

It brought to mind scenes from Mission Impossible 2. In the Tom Cruise starrer, Cruise is on a mission to fight bio terrorism and capture a deadly virus that could put the human race at risk.

The movie had a happy ending.

In real life, we are yet to see how this Corona virus situation unfolds.

Even though authorities are trying to clamp down on the virus and contain the spread, the economic cost is not limited to China.

China being the nerve centre of global production and the largest export economy in the world, the repercussions are being felt far and wide.

A recent case in point is the 17% fall in the stock price of Tesla (after a dramatic rise in its share price) as Elon Musk hinted of a delay due to supply chain disruption.

As an analyst, I find all this humbling.

In all the planning and forecasts that experts have been making about the global economy, the 'virus' certainly was never factored in. And it single-handedly now threatens to change not just the extent but the very direction of the markets.

It is too early to build in the negatives as far as impact on Indian companies are concerned.

In fact, there is a possibility that some Indian companies will benefit from a shift in outsourcing from China to India as the former faces shutdowns.

But all in all, it's better to be conservative with regards to the macro environment and to be extremely selective while betting on stocks.

Maybe it's time to think local...focus on the companies that are focused on the domestic market for their business...

Those that are independent of China or the global economy, be it the raw material need or target markets.


The chances of finding such companies in the largecap space are slim. Fortunately, we have an option.

There are quite a few smallcap stocks that not only enjoy a long runway when it comes to the opportunities in the domestic markets... But are available at attractive valuations as well.

But even among these, there is a smallcap business that I consider first among equals.

I have been tracking this company for almost 4 years now.

Amid all the economic disruptions that Indian economy has been through - demonetization, GST, GDP growth rate slowdown...this company has grown and emerged stronger year after year.

And so has my conviction in the management and their execution capabilities.

So much so, that for the first time, I am recommending subscribers to go beyond the standard allocation limit of 2%-3%, and allocate 5% instead.

This may seem too much for a single smallcap stock. But I believe this is one stock that has the potential to return crores in the long term. And when you spot a Crorepati stock, not betting big is not an option.

Curious to know more about this stock? - Click here and sign up for a free seat at my 'One Stock Crorepati' MEGA summit on 11th February.

When you click here, you will get instant access to my premium guide - Smallcaps that Will Race Ahead of Sensex for free.

To be frank, if I have to recommend just one stock to invest in the times of Coronavirus, this would be it.

The best part - It is still in the 'Buy' zone.

I hope you will make the most of this opportunity - and I'll see you here again tomorrow.

Warm regards,

Richa Agarwal
Richa Agarwal
Editor, Hidden Treasure
Equitymaster Agora Research Private Limited (Research Analyst)

PS: Existing Hidden Treasure subscribers can access the report here. For everyone else, you can also have the chance to get this stock recommendation - simply click here and sign up for a free seat at Richa's 'One Stock Crorepati' MEGA summit on 11th February.

Copyright © Equitymaster Agora Research Private Limited. All rights reserved.

Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement

Disclosure & Disclaimer: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. The Author does not hold any shares in the company/ies discussed in this document. Equitymaster may hold shares in the company/ies discussed in this document under any of its other services.

This document is confidential and is supplied to you for information purposes only. It should not (directly or indirectly) be reproduced, further distributed to any person or published, in whole or in part, for any purpose whatsoever, without the consent of Equitymaster.

This document is not directed to, or intended for display, downloading, printing, reproducing or for distribution to or use by, any person or entity, who is a citizen or resident or located in any locality, state, country or other jurisdiction, where such distribution, publication, reproduction, availability or use would be contrary to law or regulation or what would subject Equitymaster or its affiliates to any registration or licensing requirement within such jurisdiction. If this document is sent or has reached any individual in such country, especially, USA, Canada or the European Union countries, the same may be ignored.

This document does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Our research recommendations are general in nature and available electronically to all kind of subscribers irrespective of subscribers' investment objectives and financial situation/risk profile. Before acting on any recommendation in this document, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek professional advice. The price and value of the securities referred to in this material and the income from them may go down as well as up, and subscribers may realize losses on any investments. Past performance is not a guide for future performance, future returns are not guaranteed and a loss of original capital may occur. Information herein is believed to be reliable but Equitymaster and its affiliates do not warrant its completeness or accuracy. The views/opinions expressed are our current opinions as of the date appearing in the material and may be subject to change from time to time without notice. This document should not be construed as an offer to sell or solicitation of an offer to buy any security or asset in any jurisdiction. Equitymaster and its affiliates, its directors, analyst and employees will not be responsible for any loss or liability incurred to any person as a consequence of his or any other person on his behalf taking any decisions based on this document.

As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407